Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

14.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 19.50p
  • 52 Week Low: 8.92p
  • Currency: UK Pounds
  • Shares Issued: 927.98m
  • Volume: 601,540
  • Market Cap: £134.56m
  • Beta: 0.49

Latest ShareCast News

Scancell shares jump on new antibody agreement with major biotech firm

By Benjamin Chiou

Date: Wednesday 12 Jun 2024

(Sharecast News) - Scancell Holdings saw shares surge on Wednesday after the the AIM-listed oncology immunotherapies group announced an agreement with a "major international biotechnology company".

Scancell appoints healthcare finance veteran as new CFO

By Josh White

Date: Tuesday 29 Aug 2023

(Sharecast News) - Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, effective immediately.

Scancell to present positive recent findings at oncology summit

By Josh White

Date: Friday 02 Jun 2023

(Sharecast News) - Immunotherapy developer Scancell said on Friday that it is set to present an informative poster at the American Society of Clinical Oncology Meeting (ASCO) 2023 annual meeting in Chicago from 2 to 6 June.

Scancell shares jump on positive cancer vaccine ... 21-Feb-2023 ShareCast
Scancell licenses Vaccitech IP for its next vacc... 07-Nov-2022 ShareCast
Scancell enrols and doses first patient in lates... 31-Oct-2022 ShareCast
Scancell losses widen on expense of ongoing trials 28-Oct-2022 ShareCast
Scancell inks licensing deal with Nasdaq-traded ... 25-Oct-2022 ShareCast
Scancell presents new, positive data on possible... 23-Sep-2022 ShareCast
Scancell developing 'promising' new cancer treat... 23-Jun-2022 ShareCast
Scancell updates protocol for UK trial in melano... 15-Jun-2022 ShareCast
Scancell opens recruitment for cancer therapy tr... 11-Apr-2022 ShareCast
Scancell treats first patient in melanoma tumour... 19-Nov-2021 ShareCast
Scancell gets MHRA approval for Modi-1 clinical ... 26-Aug-2021 ShareCast
Scancell chooses needle-free tech for Covid vacc... 17-Aug-2021 ShareCast
Scancell makes progress with 'Covidity' trial pl... 22-Jun-2021 ShareCast
Scancell ends clinical development partnership w... 03-Feb-2021 ShareCast
Scancell selects Covid-19 vaccine candidate for ... 18-Dec-2020 ShareCast
Scancell reaches Covid-19 collaboration agreemen... 02-Oct-2020 ShareCast
Scancell upbeat on publication of AvidiMab resea... 12-Jun-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 14.50p
Change Today -0.50p
% Change -3.33 %
52 Week High 19.50p
52 Week Low 8.92p
Volume 601,540
Shares Issued 927.98m
Market Cap £134.56m
Beta 0.49

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.19% below the market average10.19% below the market average10.19% below the market average10.19% below the market average10.19% below the market average
12% below the sector average12% below the sector average12% below the sector average12% below the sector average12% below the sector average
Price Trend
50.60% above the market average50.60% above the market average50.60% above the market average50.60% above the market average50.60% above the market average
83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:29 100 @ 14.11p
16:24 46 @ 14.00p
16:23 50,285 @ 14.31p
15:24 30,000 @ 14.50p
15:23 50,000 @ 14.50p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page